BioCentury
ARTICLE | Company News

NovAliX, Fondation Jerome Lejeune deal

September 19, 2011 7:00 AM UTC

NovAliX and the foundation partnered to develop small molecules against cystathionine beta-synthase ( CBS) to treat Trisomy 21. NovAliX will be responsible for development under the two-year deal, whi...